Satoshi Kuroda – författare

Scientific and epidemiologic progress surrounding carotid artery surgery continues to evolve, and for the better, for both surgeons and patients. Carotid surgery, performed by skilled surgeons with quantifiable results, prevents stroke in asymptomatic and symptomatic patients. The challenge is to continually refine the techniques to ensure the greatest possible margins of safety, and to educate surgeons around the world to ensure uniform standards of care. Carotid artery stenting, again performed by skilled practitioners with quantifiable results, has developed as a viable alternative to CEA in chosen cases.Carotid Treatment, Third Edition represents the current state of the art in carotid treatment. Coverage includes a comprehensive and practical new chapter on carotid stenting, increased coverage of radiography, and highly illustrated surgical technique case examples reflecting international practice. Throughout the book numerous case examples, and interesting examples of anatomical variants are illustrated and explained. An expanded section on complications further increases the value of this resource for all practitioners. Highly illustrated text to aid understanding of best practice in carotid treatment Reflects international best practice Useful in clinical practice and to improve patient care Neurosurgeons, Vascular surgeons, and Neuro-Interventionalists will benefit from the experience and wisdom shared in the third edition of this acclaimed text.

This book presents comprehensive reviews for both translational research and clinical trials on cell therapy for stroke.Cerebral stroke is still a leading cause of death and disability. However, despite intensive research, few treatment options are available. The therapeutic potential of cell transplantation has been studied for various pathological conditions of the central nervous system (CNS) including traumatic brain injury, traumatic spinal cord injury, degenerative disease, demyelinating disease and ischemic stroke, as the injured neural tissue in the CNS has only a limited regenerative capacity.Recently, a growing body of evidence in this field suggests that cell transplantation holds great potential as a form of stroke therapy.The authors, who are experts in the field of neurosurgery, review and discuss optimal cell sources and various issues involved in translational research; further, they outline ongoing clinical trials in Japan.

This book presents comprehensive reviews for both translational research and clinical trials on cell therapy for stroke.Cerebral stroke is still a leading cause of death and disability. However, despite intensive research, few treatment options are available. The therapeutic potential of cell transplantation has been studied for various pathological conditions of the central nervous system (CNS) including traumatic brain injury, traumatic spinal cord injury, degenerative disease, demyelinating disease and ischemic stroke, as the injured neural tissue in the CNS has only a limited regenerative capacity.Recently, a growing body of evidence in this field suggests that cell transplantation holds great potential as a form of stroke therapy.The authors, who are experts in the field of neurosurgery, review and discuss optimal cell sources and various issues involved in translational research; further, they outline ongoing clinical trials in Japan.

This book brings together the latest knowledge on moyamoya disease, covering diagnostic criteria, status as a disease entity, genetic aspects, pathophysiology, novel neuroradiological findings, and surgical therapy.